VIRGINIA
BELLIDO CASTAÑEDA
Ikertzailea 2021-(e)ra arte
Novo Nordisk
Copenhagen, DinamarcaNovo Nordisk-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study
Journal of Clinical Medicine, Vol. 11, Núm. 17